Kelly John Alexander

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$242,436.74
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Kelly John Alexander

According to the SEC Form 4 filings, Kelly John Alexander, being in a position of

  1. Chief Financial Officer at Precision BioSciences, Inc.,
    оver the last 12 months, has bought 3000 shares for $20,280, and sold 0 shares,
    over all time since 2022-03-17, has bought 208698 shares for $242,437, and sold 0 shares.

The largest purchase of all time was on 2022-03-17 and amounted to 16677 shares of Precision BioSciences, Inc. for $51,365.

Biography of Kelly John Alexander

No biography is available at this moment.

2024-11-21PurchasePrecision BioSciences, Inc.
DTIL
Chief Financial Officer
3,000
0.0411%
$6.76$20,280-6.15%
2023-08-18PurchasePrecision BioSciences, Inc.
DTIL
Chief Financial Officer
90,000
0.0791%
$0.48$43,200+1.94%
2023-03-17PurchasePrecision BioSciences, Inc.
DTIL
Chief Financial Officer
20,000
0.0178%
$0.86$17,200-39.54%
2022-09-23PurchasePrecision BioSciences, Inc.
DTIL
Chief Financial Officer
8,200
0.0075%
$1.23$10,086-27.79%
2022-09-22PurchasePrecision BioSciences, Inc.
DTIL
Chief Financial Officer
37,037
0.0353%
$1.34$49,630-30.59%
2022-06-22PurchasePrecision BioSciences, Inc.
DTIL
Chief Financial Officer
33,784
0.05%
$1.50$50,676-17.45%
2022-03-17PurchasePrecision BioSciences, Inc.
DTIL
Chief Financial Officer
16,677
0.0249%
$3.08$51,365-56.8%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.